Health Secretary Robert F. Kennedy Jr., as well as many anti-vaccine groups, has long argued that placebo-controlled trials were the only way to fully understand vaccine side effects. To ...

Getting a shingles vaccine may help with more than the viral infection that causes painful rashes — new research shows it can also lower the risk of heart disease. In a study, published Monday ...

Now that measles, which was declared eliminated from the U.S. in 2000, has re-emerged in this country, here’s something you may be wondering about: whether you should get a measles vaccine booster.

Share on Pinterest Does the MMR vaccine’s protection against measles change over time? MNT asks experts. Image credit: Raquel Natalicchio/Houston Chronicle via Getty Images. As the measles ...

Before the measles vaccine was introduced in 1963, it is estimated that 3 to 4 million people in the U.S. contracted measles every year, causing 500 deaths and 48,000 hospitalizations annually ...

The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and Prevention — but a new study from Cleveland Clinic suggests that it might ...

One important vaccine your healthcare provider may or may not have mentioned to you yet, depending on your age and personal health profile, is the shingles vaccine. Doctors say that even people ...

Getting a COVID-19 vaccine or booster is similar to getting other vaccines and does not require any specific preparation. However, you can take some steps to reduce side effects and improve ...

There is no antiviral treatment for the miserable but thankfully short-lived illness, and no vaccine—yet. But scientists at Moderna are in the late stages of testing what could be the first such ...

The only way to restore public trust in vaccination – which has taken a big hit since the lies attending the rollout of the COVID-19 vaccine – is to put a well-known vaccine skeptic in charge ...

Brisbane-based vaccine patch company Vaxxas is developing the first room temperature-stable needleless vaccine for one of the world’s most common cold-like diseases, weeks after launching efforts to ...